Convenient once-a-day oral medication approved for both the initial and maintenance treatment of severe psoriasis (BSA greater than 10%) in adults. (Teratogenic in humans. In females of reproductive potential, it should be reserved for non-pregnant patients with severe psoriasis who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments.)
Post new comment